XML 17 R5.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
Total
Common Stock, Prefunded Warrants and Stock Warrants
Public Offering
Private Placement
Aventis Inc.
Class A Common Stock
Class B Common Stock
Common Stock
Class A Common Stock
Common Stock
Class A Common Stock
Common Stock, Prefunded Warrants and Stock Warrants
Common Stock
Class A Common Stock
Public Offering
Common Stock
Class A Common Stock
Private Placement
Common Stock
Class A Common Stock
Private Placement
Aventis Inc.
Common Stock
Class B Common Stock
Additional Paid-In Capital
Additional Paid-In Capital
Common Stock, Prefunded Warrants and Stock Warrants
Additional Paid-In Capital
Public Offering
Additional Paid-In Capital
Private Placement
Aventis Inc.
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023             29,271,629         0            
Beginning balance at Dec. 31, 2023 $ 90,576,183           $ 29,272         $ 0 $ 253,806,267       $ (778) $ (163,258,578)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Issuance of common stock upon exercise of stock options (in shares)             229,299                      
Issuance of common stock upon exercise of stock options 732,458           $ 229           732,229          
Issuance of common stock through employee stock purchase plan (in shares)             152,427                      
Issuance of common stock through employee stock purchase plan 247,465           $ 152           247,313          
Stock-based compensation expense 1,474,758                       1,474,758          
Net loss (14,307,829)                                 (14,307,829)
Other comprehensive income (loss) (306)                               (306)  
Ending balance (in shares) at Mar. 31, 2024             29,653,355         0            
Ending balance at Mar. 31, 2024 78,722,729           $ 29,653         $ 0 256,260,567       (1,084) (177,566,407)
Beginning balance (in shares) at Dec. 31, 2023             29,271,629         0            
Beginning balance at Dec. 31, 2023 90,576,183           $ 29,272         $ 0 253,806,267       (778) (163,258,578)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Net loss (42,985,123)                                  
Ending balance (in shares) at Sep. 30, 2024             31,050,448         0            
Ending balance at Sep. 30, 2024 57,720,814           $ 31,050         $ 0 263,925,619       7,845 (206,243,700)
Beginning balance (in shares) at Mar. 31, 2024             29,653,355         0            
Beginning balance at Mar. 31, 2024 78,722,729           $ 29,653         $ 0 256,260,567       (1,084) (177,566,407)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Stock-based compensation expense 1,661,749                       1,661,749          
Net loss (14,079,927)                                 (14,079,927)
Other comprehensive income (loss) 1,084                               1,084  
Ending balance (in shares) at Jun. 30, 2024             29,653,355         0            
Ending balance at Jun. 30, 2024 66,305,635           $ 29,653         $ 0 257,922,316       0 (191,646,334)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Issuance of common stock under at-the-market offering, net of issuance costs (in shares)             1,318,752                      
Issuance of common stock under at-the-market offering, net of issuance costs 4,237,397           $ 1,319           4,236,078          
Issuance of common stock through employee stock purchase plan (in shares)             78,341                      
Issuance of common stock through employee stock purchase plan 127,187           $ 78           127,109          
Stock-based compensation expense 1,640,116                       1,640,116          
Net loss (14,597,366)                                 (14,597,366)
Other comprehensive income (loss) 7,845                               7,845  
Ending balance (in shares) at Sep. 30, 2024             31,050,448         0            
Ending balance at Sep. 30, 2024 57,720,814           $ 31,050         $ 0 263,925,619       7,845 (206,243,700)
Beginning balance (in shares) at Dec. 31, 2024         31,050,448 0 31,050,448         0            
Beginning balance at Dec. 31, 2024 41,386,226           $ 31,050         $ 0 265,650,362       0 (224,295,186)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Issuance of common stock under at-the-market offering, net of issuance costs (in shares)             4,836,804                      
Issuance of common stock under at-the-market offering, net of issuance costs 13,676,667           $ 4,837           13,671,830          
Issuance of common stock through employee stock purchase plan (in shares)             98,450                      
Issuance of common stock through employee stock purchase plan 133,892           $ 98           133,794          
Stock-based compensation expense 1,692,267                       1,692,267          
Net loss (15,046,132)                                 (15,046,132)
Ending balance (in shares) at Mar. 31, 2025             35,985,702         0            
Ending balance at Mar. 31, 2025 41,842,920           $ 35,985         $ 0 281,148,253       0 (239,341,318)
Beginning balance (in shares) at Dec. 31, 2024         31,050,448 0 31,050,448         0            
Beginning balance at Dec. 31, 2024 $ 41,386,226           $ 31,050         $ 0 265,650,362       0 (224,295,186)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Issuance of common stock upon exercise of stock options (in shares) 48,825                                  
Net loss $ (44,444,888)                                  
Ending balance (in shares) at Sep. 30, 2025         63,483,397 0 63,483,397         0            
Ending balance at Sep. 30, 2025 227,976,432           $ 63,483         $ 0 496,653,023       0 (268,740,074)
Beginning balance (in shares) at Mar. 31, 2025             35,985,702         0            
Beginning balance at Mar. 31, 2025 41,842,920           $ 35,985         $ 0 281,148,253       0 (239,341,318)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Issuance of common stock upon exercise of stock options (in shares)             1,604                      
Issuance of common stock upon exercise of stock options 2,055           $ 2           2,053          
Stock-based compensation expense 1,524,943                       1,524,943          
Net loss (14,433,881)                                 (14,433,881)
Ending balance (in shares) at Jun. 30, 2025             35,987,306         0            
Ending balance at Jun. 30, 2025 28,936,037           $ 35,987         $ 0 282,675,249       0 (253,775,199)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Issuance of common stock under at-the-market offering, net of issuance costs (in shares)             327,355 5,251,349 18,959,914 2,708,559                
Issuance of common stock under at-the-market offering, net of issuance costs 1,343,379 $ 23,394,173 $ 164,086,975 $ 23,300,000     $ 327 $ 5,251 $ 18,960   $ 2,709   1,343,052 $ 23,388,922 $ 164,068,015 $ 23,297,291    
Issuance of common stock upon exercise of stock options (in shares)             47,221                      
Issuance of common stock upon exercise of stock options 136,645           $ 47           136,598          
Issuance of common stock through employee stock purchase plan (in shares)             201,693                      
Issuance of common stock through employee stock purchase plan 288,018           $ 202           287,816          
Stock-based compensation expense 1,456,080                       1,456,080          
Net loss (14,964,875)                                 (14,964,875)
Ending balance (in shares) at Sep. 30, 2025         63,483,397 0 63,483,397         0            
Ending balance at Sep. 30, 2025 $ 227,976,432           $ 63,483         $ 0 $ 496,653,023       $ 0 $ (268,740,074)